Indegene has expanded its global delivery operations with a new center in Hyderabad. As the pharma industry faces increasing pressure to innovate and adapt, this new center will play a key role in helping companies accelerate their transformation. This move aligns with Indegene’s purpose: to enable healthcare organizations to be future-ready by combining deep medical expertise with fit-for purpose technology.
India is rapidly emerging as a critical hub for global pharma companies, fueled by its vast pool of skilled medical and technology talent. These companies are increasingly seeking a partner with core domain expertise and life sciences-contextualized technology to help them scale their operations in a non-linear, technology-led way.
Indegene’s leadership in life sciences commercialization has been further recognized by the Everest Group, which named the company a Leader in its Life Sciences Digital Services Specialist PEAK Matrix Assessment 2024. Additionally, HFS Research recently recognized Indegene as a Leader in GenAI in Life Sciences, further validating the latter’s ongoing commitment to innovation and excellence in the industry.
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies, many emerging biotech firms, and medical device companies. This vast global footprint underscores Indegene’s ability to scale and meet the evolving needs of the world’s leading pharma organizations across markets.
Indegene’s Enterprise Commercial Solutions primarily involve assisting life sciences companies with their digital marketing operations.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1798.60 |
Dr. Reddys Lab | 1225.10 |
Cipla | 1534.40 |
Lupin | 2081.40 |
Zydus Lifesciences | 982.20 |
View more.. |